Raluca Maria Fostea
2PUBLICATIONS
3CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (2)
Sort by Publication Date:
|Aug 17, 2022
Sustained Tumor Regression With Zenocutuzumab, a Bispecific Antibody Targeting Human Epidermal Growth Factor Receptor 2/Human Epidermal Growth Factor Receptor 3 Signaling, in <i>NRG1</i> Fusion-Positive, Estrogen Receptor-Positive Breast Cancer After Progression on a Cyclin-Dependent Kinase 4/6 Inhibitor.Elisa Fontana, Gonzalo Torga, Raluca Fostea
|Jan 27, 2022
Trifluridine/tipiracil in the treatment of gastric cancer.Raluca Maria Fostea, Hendrik-Tobias Arkenau
Pageof 1

